Leaderboard

En | De
Sie sind hier: Hämatologie » Anderes 30. September 2026
Suchen
medline.ch
Anderes
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Anämie
Gerinnungsstörungen
Neoplasie
Anderes
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 4697  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 93926  
   
Uveitis as a class effect of Bruton tyrosine kinase inhibitors: ibrutinib and zanubrutinib ocular toxicity.
BMJ Case Rep
Beresford O, Ooi ZY, Al-Bermani A.
PMID: 42810753 [PubMed - indexed for MEDLINE]


Toward a Cure in Multiple Myeloma: Redefining Induction Therapy and the Role of Autologous Stem Cell Transplant.
Cancer J
Joshi A, Puliafito BR, Cirstea DD, Branagan AR, Gustine JN, Shome R, Panaroni C, Yee AJ, Raje NS.
PMID: 42809701 [PubMed - indexed for MEDLINE]


Tailoring Therapy for Frail and Elderly Myeloma Patients.
Cancer J
George T, Szalat RE.
PMID: 42809700 [PubMed - indexed for MEDLINE]


Managing Novel CAR T-Cell Toxicities in Multiple Myeloma.
Cancer J
Ang KK, Lipof J, Kumar A, Mikkilineni L, Chung A, Arora S, Sayre P, Wolf J, Chari A, Martin T, Pan D.
PMID: 42809699 [PubMed - indexed for MEDLINE]


T-Cell Redirecting Antibodies for the Treatment of Multiple Myeloma: Off-the-Shelf T-Cell Immunity.
Cancer J
van de Donk NWCJ, Smits F, O'Neill C, Hoekman J, Kruyswijk S, Baglio SR, Zweegman S, Korst CLBM.
PMID: 42809698 [PubMed - indexed for MEDLINE]


CAR-T Cell Therapy: Engineering Remission in Refractory Myeloma.
Cancer J
Sperling AS.
PMID: 42809697 [PubMed - indexed for MEDLINE]


Minimal Residual Disease (MRD) in Multiple Myeloma: From Prognostic Marker to Therapeutic Compass.
Cancer J
Tamariz-Amador LE, Rodriguez-Otero P, Manubens A, Lasa M, Gonzalez C, Paiva B, San-Miguel J.
PMID: 42809696 [PubMed - indexed for MEDLINE]


Monoclonal Antibodies and Antibody-Drug Conjugates: Expanding the Therapeutic Arsenal in Multiple Myeloma.
Cancer J
Ntanasis-Stathopoulos I, Terpos E, Dimopoulos MA.
PMID: 42809695 [PubMed - indexed for MEDLINE]


Proteostasis as a Therapeutic Backbone: Proteasome Inhibitors and Emerging Regimens.
Cancer J
Song Y, Theprungsirikul P, Gulla A, Anderson KC.
PMID: 42809694 [PubMed - indexed for MEDLINE]


Beyond Immunomodulatory Drugs: Next-Generation Cereblon Modulators in Multiple Myeloma.
Cancer J
Cani L, Mina R, Lonial S.
PMID: 42809693 [PubMed - indexed for MEDLINE]


Smoldering and Early Disease Interception.
Cancer J
Puertas B, Alejo E, Mateos MV.
PMID: 42809692 [PubMed - indexed for MEDLINE]


Risk Stratification in Myeloma: Defining Precision in the Genomic Era.
Cancer J
Schavgoulidze A, Corre J.
PMID: 42809691 [PubMed - indexed for MEDLINE]


Scleromyxedema-Associated Myopathy and Vacuolar Myopathy with Monoclonal Gammopathy and Stiffness (VAMMGAS) as manifestations of Monoclonal Gammopathy of Clinical Significance (MGCS): a disease spectrum between autophagy dysfunction and inflammation.
J Neurol
Nicoletti T, Benveniste O, Battistella M, Mahevas T, Arnulf B, Stojkovic T, Staedler K, Maisonobe T, Letournel F, Romero P, Malfatti E, Vignon M, Nadaj-Pakleza A, Labella B, Lacene E, Brochier G, Evangelista T, Leonard-Louis S.
PMID: 42809155 [PubMed - indexed for MEDLINE]


Case Report: Confirmed and suspected heparin-induced thrombocytopenia during therapeutic plasma exchange in neuromyelitis optica spectrum disorder: a single-centre case series.
Front Immunol
Podlecka-Pi, Rychter J, Sujkowska K, Zakrzewska-Pniewska B, Nojszewska M.
PMID: 42807460 [PubMed - indexed for MEDLINE]


Molecular confirmation of transfusion-transmitted dengue virus infection following platelet transfusion in the Chinese mainland.
Front Cell Infect Microbiol
Huang J, Xu R, Liu B, Liao Q, Wang M, Shan Z, Zhong H, Liao F, Liang H, Wang H, Li S, Fu Y, Liang H, Rong X.
PMID: 42807290 [PubMed - indexed for MEDLINE]


Clinical Impact of CTLA4 and LAG3 Single-Nucleotide Polymorphisms in Multiple Myeloma Patients Treated With BCMA CAR T-Cell Therapy.
Hematol Oncol
Suter E, Bertschinger M, Shaforostova I, Kronig MN, Nilius H, Bacher U, Seipel K, Pabst T.
PMID: 42806527 [PubMed - indexed for MEDLINE]


Primary G-CSF prophylaxis in sacituzumab govitecan-treated mTNBC: real-world evidence from a multinational CEBCC-102 cohort.
Support Care Cancer
Miros, Anna PG, Aleksandra K, Ma, Justyna , Milo, Renata S, Hana , Miroslava M, Agnieszka M, Karolina WS, Maja LH, Anika P, Daniel K, Jan , Iveta K, Iwona D, Magdalena SR, Tomasz C, Lenka R, Bogumi, Aleksandra , Renata PM, Micha, Zuzana B, Marcin K.
PMID: 42806055 [PubMed - indexed for MEDLINE]


Abemaciclib and lenalidomide presenting with central retinal artery occlusion in a patient with breast cancer and multiple myeloma: a possible treatment-related association.
BMJ Case Rep
Pustake M, Ongsyping S, Gomez J, Corral J.
PMID: 42805625 [PubMed - indexed for MEDLINE]


Neutrophil recovery characteristics in patients with severe antithyroid drug-induced agranulocytosis: A 12-year retrospective study.
Endocrine
Luo Y, Fan X, Yang Q, Liu H, Liu Y, Wang Y, Guo H, Shi B, Zhang B, He Y.
PMID: 42803895 [PubMed - indexed for MEDLINE]


Recurrent multiterritorial ischemic stroke with persistent moderate hypereosinophilia: A case report with focused literature review.
J Int Med Res
Wang Y, Liu N, Zhu J.
PMID: 42803733 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 93926    Seite 1 von 4697  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1